Type I tumours are preferentially associated with genetic alterations in PTEN, KRAS, CTNNB1 and PIK3CA and MLH1 promoter hypermethylation, whereas type II, especially serous histotypes, prototypically harbour TP53 mutations [42]. Here, TP53 is linked to neoplasm.